We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses.
- Authors
Bourke, J. F.; Berth-Jones, J.; Holder, J.; Grahm-Brown, R. A. C.
- Abstract
Cyclosporin is a highly effective treatment for severe psoriasis and atopic dermatitis. However, both inter- and intrapatient gastrointestinal absorption of the conventional formulation of cyclosporin (Sandimmun) are very variable, ranging from 20 to 50%. Variations in bioavailability may explain isolated resistance to therapy. Neoral is a novel microemulsion formulation of cyclosporin which has been developed to enhance and standardize its absorption. We report the first experience with Neoral in patients with psoriasis and atopic dermatitis refractory to Sandimmun.
- Subjects
SKIN diseases; CYCLOSPORINE; ATOPIC dermatitis; ALLERGIES; BIOCHEMISTRY; EMULSIONS (Pharmacy)
- Publication
British Journal of Dermatology, 1996, Vol 134, Issue 4, p777
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1111/j.1365-2133.1996.tb06990.x